Abbott to Buy Facet Biotech

March 9, 2010, 5:31 am by Wall Street Journal

Abbott Labs will bulk up its product pipeline with a $722 million deal for Facet Biotech, which had rebuffed overtures from development partner Biogen Idec.

Read the full article

More from Wall Street Journal

For Wounded Vet, Love Pierces the Fog of War
Wall Street Journal : February 3, 2012, 8:33 am
Katie Brickman is both Ian Welch's girlfriend and his government-paid caregiver. Mr. Welch, a former Marine, is dealing with post-traumatic shock from his service in Iraq.

Komen Reverses on Planned Parenthood
Wall Street Journal : February 3, 2012, 4:24 am
The Susan G. Komen for the Cure breast-cancer charity said it was reversing its decision to cut breast-screening grants to Planned Parenthood.

Walgreen Same-Store Sales Decline
Wall Street Journal : February 3, 2012, 2:22 am
Walgreen's same-store sales slid 4.6% in January as the drugstore chain's prescriptions sales were battered by the loss of major customer Express Scripts.

Study: Hospitals Overpay for Devices
Wall Street Journal : February 2, 2012, 10:41 am
Some hospitals pay thousands of dollars more than others for big-ticket medical devices such as defibrillators, and a portion of the higher costs could be passed on to Medicare.

Nonprofits' Backers Mobilize
Wall Street Journal : February 2, 2012, 10:10 am
The Susan G. Komen for the Cure breast-cancer charity grappled with the fallout from its decision to cut funding for Planned Parenthood affiliates, as both groups saw a surge in donations.